임상시험 트래커

추적 기업 30곳의 임상 6,982건 (국내 전체 이력 · 글로벌 진행 중). 출처: ClinicalTrials.gov

23건 표시

4상모집 예정· Chronic Graft Versus Host Disease
A Study to Investigate Safety of Belumosudil in Participants Aged 12 Years and Above, With Chronic Graft-versus-host Disease (cGVHD)
리드: 사노피
상세 →NCT07135973
4상모집 예정· Chronic Obstructive Pulmonary Disease (COPD)
This After Market Study is Seeing if Dupilumab Plus Usual Standard of Care (SOC) is Better Than Usual Care Alone for Adult Participants After a Severe Chronic Obstructive Pulmonary Disease (COPD) Flare-Up Requiring Hospitalization
리드: 리제네론 · 협력: 사노피
상세 →NCT07587658
4상모집 중· Polymyalgia Rheumatica
Sarilumab Efficacy and Safety in Adults With Early Polymyalgia Rheumatica
리드: 사노피 · 협력: 리제네론
상세 →NCT07286214
4상모집 중· Type 2 Diabetes
Efficacy and Safety of iGlarLixi Versus Standard of Care in a Real-world Adult China Population With Uncontrolled Type 2 Diabetes on Oral Agents
협력: 사노피
상세 →NCT07307235
4상모집 중단 (진행 중)· Volunteers
Impact of FLU Vaccination on Nasal Resident Memory Immune Responses and Peripheral Respiratory-tropic Memory Immune Responses
협력: 사노피
상세 →NCT06824779
4상모집 중단 (진행 중)· COVID-19
Efficacy and Safety of NVX-CoV2705
협력: 사노피
상세 →NCT07086222
4상모집 중· Factor VIII Deficiency
Efanesoctocog Alfa Prophylaxis in Patients With Hemophilia A With Synovial Hypertrophy
리드: 사노피
상세 →NCT06941870
4상모집 중· Chronic Obstructive Pulmonary Disease
A Study to Investigate Airway Inflammation With Dupilumab Subcutaneously in Participants Aged ≥40 to ≤85 Years With Chronic Obstructive Pulmonary Disease.
리드: 사노피 · 협력: 리제네론
상세 →NCT07053423
4상모집 중단 (진행 중)· RSV Immunization
Study of Monoclonal Antibody Nirsevimab Against Respiratory Syncytial Virus (RSV) in Participants up to 24 Months of Age in India
리드: 사노피
상세 →NCT07109297
4상모집 중· Multiple Sclerosis
Glucose Consumption in MS Using [F-18]FDG-PET
협력: 사노피
상세 →NCT07087106
4상모집 중· Glycogen Storage Disease Type II
China Post-approval Commitment (PAC) Study of Avalglucosidase Alfa in Participants With IOPD
리드: 사노피
상세 →NCT06666413
4상모집 중· Type 2 Diabetes (T2D)
iGlarLixi CGM Study in Chinese T2D Individuals After OADs
리드: 사노피
상세 →NCT06671587
4상모집 중단 (진행 중)· Asthma
Efficacy of Dupilumab Added to Medium Dose Inhaled Corticosteroid/Long-acting Beta-agonist (ICS/LABA) in Comparison to ICS Dose Escalation to High Dose ICS/LABA in Adolescent and Adult Patients With Uncontrolled Asthma
리드: 리제네론 · 협력: 사노피
상세 →NCT06572228
4상모집 예정· Chronic Rhinosinusitis With Nasal Polyps
Immunologic Impact of Dupilumab in Patients Suffering From Asthma and Chronic Rhinosinusitis With Polyps
협력: 사노피
상세 →NCT06556264
4상모집 중단 (진행 중)· Eosinophilic Esophagitis
Dupilumab for Eosinophilic Esophagitis With Severe Strictures
협력: 리제네론, 사노피
상세 →NCT06352073
4상모집 중· Hemophilia A
A Study to Test a Medicine (Fitusiran) for Preventing Bleeds in People With Severe Hemophilia Who Previously Received Preventive Treatment With Emicizumab
리드: 사노피
상세 →NCT06145373
4상모집 중단 (진행 중)· Dermatitis Atopic
A Study of Long-term Effect of Dupilumab on Skin Barrier Function in Pediatric Participants With Atopic Dermatitis
리드: 사노피 · 협력: 리제네론
상세 →NCT05983068
4상모집 중단 (진행 중)· Eosinophilic Oesophagitis
A Study Assessing Esophageal Function and Remodeling With Dupilumab Compared With Placebo for 24 Weeks Followed by 104 Weeks Open Label in Adult Participants With EoE (REMOdeling With Dupilumab in Eosinophilic Esophagitis Long-term Trial)
리드: 사노피 · 협력: 리제네론
상세 →NCT06101095
4상모집 중단 (진행 중)· Diabetes Mellitus, Type 1
Teplizumab in Pediatric Stage 2 Type 1 Diabetes
리드: 사노피
상세 →NCT05757713
4상모집 중단 (진행 중)· Glycogen Storage Disease Type II Late Onset
Safety and Efficacy of Avalglucosidase Alfa in Patients With Non-classic Pompe Disease Aged ≥ 5 Years
협력: 사노피
상세 →NCT07652814
4상모집 중단 (진행 중)· Glycogen Storage Disease Type II
Avalglucosidase Alfa French Post-trial Access for Participants With Pompe Disease (PTA Avalglucosidase)
리드: 사노피
상세 →NCT05164055
4상모집 중단 (진행 중)· Asthma
Study Assessing the Long-term Effect of Dupilumab on Prevention of Lung Function Decline in Adult Patients With Uncontrolled Moderate to Severe Asthma
리드: 사노피 · 협력: 리제네론
상세 →NCT05097287
4상모집 중단 (진행 중)· Asthma
Investigating Dupilumab's Effect in Asthma by Genotype
협력: 머크(MSD), 리제네론, 사노피
상세 →NCT03694158

BioPulse가 제공하는 정보는 공개된 자료를 요약·정리한 것으로, 투자 조언이나 의료 조언이 아닙니다. 임상 데이터·규제 일정·공시 내용은 반드시 원문을 직접 확인하시기 바랍니다.